Mifobate Inhibitor

Name: Mifobate Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5755186
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755186

Mifobate is a potent and specific antagonist of PPARgamma. Mifobate shows antiobesity, antidiabetic and antiatherosclerotic effects[1]. More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Mifobate, Inhibitor

Full Product Name

Mifobate

Product Synonym Names

SR-202

Form/Format

Solid. Powder

Purity/Purification

100.00%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

358.65

Solubility

H2O: 35.87mg/mL (100.01mM) Need ultrasonic and warming
(<1mg/ml refers to the product slightly soluble or insoluble)

Formula

C11H17ClO7P2

SMILES

COP(=O)(OC)OC(C1=CC=C(Cl)C=C1)P(=O)(OC)OC

CAS Number

76541-72-5

Target & IC50

PPARgamma: ic50 140uM (IC50)

Product Categories/Family for Mifobate, inhibitor

Metabolism; PPAR

Product References and Citations for Mifobate, inhibitor

Rieusset J, et al. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesityand antidiabetic activity. Mol Endocrinol. 2002 Nov;16(11):2628-44.
Rieusset J, et al. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesityand antidiabetic activity. Mol Endocrinol. 2002 Nov;16(11):2628-44.
Doggrell S. Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs[J]. Expert Opinion on Investigational Drugs, 2003, 12(4):713-716.
Doggrell S. Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs[J]. Expert Opinion on Investigational Drugs, 2003, 12(4):713-716.

Other Notes

Small volumes of Mifobate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Mifobate purchase

MBS5755186 is an inhibitor targeting Mifobate.